Skip to content

Eton Pharmaceuticals, Inc. ETON Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1M-200%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$4K-99.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$55.6M-1,638%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+162%
Enterprise value$942.39M+156%
P/S10.7×+3.4×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s other noncash income (expense)?
Eton Pharmaceuticals, Inc. (ETON) reported other noncash income (expense) of -$7K in Q1 2026.
What does other noncash income (expense) mean?
This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.